Sponsors
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Editor NGP Europe
Tough competition
The battle between generics and branded products has been going on for a long time: the claims and counter claims over Aspirin, for example, have been in process since the early 20th century.06 Aug 2009
White Papers
Focus Area: Research & Development
Making the right decision
This article looks at the value of outsourcing research and development capabilities.
Recruitment and retention: major challenges in clinical research
By Andrew Smith, Institute of Clinical Research
A bitter pill for generics
New EU legislation will soon impact the generic drug industries of the new member states ? and potentially their healthcare systems.
The IT antidote
The pharmaceutical industry is on the cusp of an adapt-or-die stage in its evolution ? but the latest generation of IT support tools are proving invaluable as it tackles the spiralling costs and regulatory demands associated with clinical trials.
A clinical approach to outsourcing
NGP speaks to Deb Brewer, Vice President of International Business Development and Marketing at Omnicare Clinical
Research
Source: www.ngpharma.eu.com© 2010 GDS Publishing Ltd. All rights reserved.